Fierce Pharma

NOVEMBER 1, 2024

With a positive readout for metabolic dysfunction-associated steatohepatitis (MASH) now in the bag, Novo Nordisk is gearing up to pursue yet another indication for its star GLP-1 medicine semagluti | Novo Nordisk on Friday revealed that its star GLP-1 semaglutide met the mark in a late-stage MASH study. The positive results build on the thesis that GLP-1s could become a foundational piece in the treatment paradigm for the fatty liver disease, according to analysts at William Blair.

Medicine 330

Medicine 330

Referral MD

NOVEMBER 1, 2024

MT. PLEASANT, S.C. , Nov. 1, 2024 /PRNewswire-PRWeb/ — ReferralMD, a leader in healthcare technology solutions, announced today that it was recognized as a 2024 Top Company in Conversational AI upon the conclusion of extensive research and company outreach by AVIA Marketplace, the leading digital health marketplace. ReferralMD offers a comprehensive platform that seamlessly integrates with Electronic Health Records (EHR), Practice Management, and Scheduling systems, automating time-consu

Healthcare 104

Healthcare Healthcare Management CRM 104

Fierce Pharma

NOVEMBER 1, 2024

An FDA announcement last year of an investigation into the risk of patients developing secondary cancers following the treatment of CAR-T cell therapies sent shock waves across the industry. | An FDA investigation last year into the risk of patients developing secondary cancers following the treatment of CAR-T cell therapies sent shock waves across the industry.

FDA 293

FDA Safety Pharma Patients 293

Pharmaceutical Technology

NOVEMBER 1, 2024

Verastem Oncology has concluded the rolling submission of a new drug application (NDA) to the US Food and Drug Administration (FDA) for a combination of avutometinib and defactinib for low-grade serous ovarian cancer (LGSOC).

Food and Drug Administration 102

Food and Drug Administration Food FDA 102

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

Fierce Pharma

NOVEMBER 1, 2024

Despite its unique ability to block sodium-glucose linked transporter 2 (SGLT2) in the kidneys and SGLT1 in the intestines, Lexicon’s Zynquista (sotagliflozin) has had difficulty negotiating r | Despite its unique ability to block sodium-glucose linked transporter 2 (SGLT2) in the kidneys and SGLT1 in the intestines, Lexicon’s Zynquista (sotagliflozin) has had difficulty negotiating regulatory hurdles.

Transportation 260

Transportation FDA Medical 260

MedCity News

NOVEMBER 1, 2024

Hear executives from Quantum Health, Surescripts, EY, Clinical Architecture and Personify Health share their views on digital transformation in healthcare. The post Heard at HLTH 2024 Part 2: Insights from Innovative Healthcare Executives appeared first on MedCity News.

Healthcare 100

Healthcare Healthcare 100

PharmaVoice

NOVEMBER 1, 2024

Almost a year after two historic approvals, Pfizer is pulling a sickle cell disease treatment from the market, and the outlook for patients feels shakier. But there’s still hope in the pipeline.

Patients 101

Patients Marketing 101

Fierce Pharma

NOVEMBER 1, 2024

After prior settlements, Apotex and Heritage hand over a combined $49M to resolve longstanding price-fixing claims fkansteiner Fri, 11/01/2024 - 10:19

180

180

MedCity News

NOVEMBER 1, 2024

The ability to reduce physician burnout is one of the most exciting things about AI, said CHAI CEO Brian Anderson. In his view, ambient listening AI could end up changing the healthcare delivery world in a similar way that the advent of the sewing machine changed the textile and fashion industry in the 1840s. The post The Sewing Machine Changed American Industry Forever — Ambient Listening Tools Could Have a Similar Effect in Healthcare appeared first on MedCity News.

Healthcare 98

Healthcare Healthcare Physicians 98

pharmaphorum

NOVEMBER 1, 2024

FDA advisors vote against Lexicon Pharma's type 1 diabetes and chronic kidney disease therapy sotagliflozin ahead of December verdict

FDA 105

FDA Pharma 105

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

MedCity News

NOVEMBER 1, 2024

To improve outcomes further, healthcare providers will need to take bold action to diagnose and manage this kidney disease before it becomes chronic or fatal. The post Innovations Shaping the Future of Kidney Care appeared first on MedCity News.

Healthcare Provider 97

Healthcare Provider Healthcare Healthcare Management 97

pharmaphorum

NOVEMBER 1, 2024

With artificial intelligence technologies for healthcare on the rise, UK health technology assessment (HTA) agency NICE has published an economic evaluation standard that it says will help inform coverage and reimbursement decisions.

Healthcare 87

Healthcare Healthcare 87

MedCity News

NOVEMBER 1, 2024

GoodRx announced a new e-commerce solution starting with over-the-counter birth control pill Opill. It also is offering new affordability programs for menopause medications with Pfizer. The post GoodRx Expands Women’s Health Options with New Birth Control and Menopause Offerings appeared first on MedCity News.

Medical 93

Medical 93

Pharmaceutical Commerce

NOVEMBER 1, 2024

Analysis finds that while basic Part D coverage costs have decreased by 4%, mid- and high-tier plans have seen hikes of 4% and 21%, respectively.

97

97

Advertisement

MedCity News

NOVEMBER 1, 2024

Novo Nordisk’s Wegovy achieved statistically significant improvement in a Phase 3 study in the fatty liver disease MASH. Based on these preliminary results, the company plans to seek U.S. and European Union approvals in this indication in 2025. The post Novo Nordisk GLP-1 Drug Meets Goals of MASH Trial, Setting Stage for FDA & EMA Filings appeared first on MedCity News.

FDA 90

FDA Biopharma Pharma 90

Copyright Clearance Center

NOVEMBER 1, 2024

The Women’s Edge and Globe Magazine celebrate the state’s leading companies and nonprofit organizations led by women.

Leads 98

Leads 98

MedCity News

NOVEMBER 1, 2024

Tomorrow’s goal scoring companies will go on offense today by giving an assist to their caregiving team members. The post Create a Winning Playbook for Employee Caregivers appeared first on MedCity News.

90

90

Pharmaceutical Technology

NOVEMBER 1, 2024

The US District Court upholds the FDA’s approval of Avadel’s Lumryz, dismissing Jazz’s challenge over market exclusivity for its own drug.

Marketing 64

Marketing 64

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales

MedCity News

NOVEMBER 1, 2024

Executives from Imagine360, Verily, BrightInsight, Lantern, and Rhapsody shared their approaches to reducing healthcare costs and facilitating digital transformation. The post Heard at HLTH 2024: Insights from Innovative Healthcare Executives appeared first on MedCity News.

Healthcare 75

Healthcare Healthcare 75

pharmaphorum

NOVEMBER 1, 2024

Eisai and Biogen complete their rolling application in the US for a subcutaneous formulation of Alzheimer's disease therapy Leqembi

62

62

PharmaTech

NOVEMBER 1, 2024

The system is Hapman’s first major product launch since 2008, following a year of intensive R&D that builds upon the company’s eight decades of tubular drag conveyor expertise.

52

52

Pharma Marketing Network

NOVEMBER 1, 2024

The world of pharma marketing is changing rapidly, and 2025 will be no exception. For pharma marketing executives, adapting to these shifts isn’t just about keeping up—it’s about staying ahead. From digital transformation and personalized marketing to compliance and competition, the upcoming years will demand flexibility and innovative thinking. So, what will be the top challenges in 2025, and how can pharma marketers tackle them?

Marketing 52

Marketing Pharma Ethics Healthcare Provider 52

Advertisement

Distribution

European Pharmaceutical Review

NOVEMBER 1, 2024

The worldwide pharmaceutical container packaging market is expected to rise in revenue from $104.12 billion in 2025 to approximately $174.45 billion by 2033, according to a study published by Towards Packaging. The research expects that the market will expand at a CAGR of 6.49 percent between 2024 and 2033. Sustainability Key factors contributing to growth of the market include sustainability trends “like waste reduction and resource conservation”.

Marketing 52

Marketing Pharmaceutical Pharma Medical 52

Pharma Marketing Network

NOVEMBER 1, 2024

Pharmaceutical marketing moves fast. In an industry where new technologies, regulations, and consumer expectations are constantly shifting, staying informed is critical for marketing success. For pharma marketing executives, tracking news isn’t just about staying updated—it’s about staying competitive. This guide will outline effective ways to stay on top of pharmaceutical marketing news, so you’re always ready to make informed, timely decisions.

Marketing 52

Marketing Pharmaceutical Pharma Networking 52

PharmExec

NOVEMBER 1, 2024

The subcutaneous form of Leqembi was previously granted Fast Track designation by the FDA to treat mild cognitive impairment or mild dementia associated with Alzheimer disease based on data from the Clarity AD study.

FDA 52

FDA 52

Healthcare Success

NOVEMBER 1, 2024

Our Senior Marketing Strategist, Kathy Gaughran, recently shared invaluable insights at the 2024 Mental Health Marketing (MHM) conference about how to reach consumers during their healthcare journey. Since her session wasn’t recorded at the venue, I interviewed Kathy on our podcast so we could share her insights with our wider audience. Whether your healthcare business is mental health focused or not, I invite you to listen and discover: Key Takeaways The Consumer Journey Today’s healthcare cons

Healthcare 52

Healthcare Healthcare Marketing Media 52

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

PharmExec

NOVEMBER 1, 2024

Results from Part I of the Phase III ESSENCE trial found that Wegovy 2.4 mg achieved a 37% improvement in liver fibrosis without worsening steatohepatitis in patients with metabolic dysfunction-associated steatohepatitis compared to 22.5% in the placebo group.

Patients 52

Patients 52

PharmaTech

NOVEMBER 1, 2024

In this episode of Drug Digest, industry experts discuss the ongoing development of automating biomanufacturing processes, including its challenges and practical applications.

52

52

Pharmaceutical Commerce

NOVEMBER 1, 2024

In the first part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Delphine Perridy, chief commercial officer, Envirotainer, describes the progression of expectations when it comes to the sector, specifically as it relates to new drug development.

Pharma 52

Pharma 52

PharmExec

NOVEMBER 1, 2024

Ted Sweetser, VP, Ad Partnerships and Strategy, PurpleLab discussed how the use of Real-World Data has evolved in the healthcare industry in terms of privacy and targeting effectiveness.

Healthcare 52

Healthcare Healthcare 52

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution